IBDEI1R7 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29774,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29774,1,1,0)
 ;;=1^J9209
 ;;^UTILITY(U,$J,358.3,29774,1,3,0)
 ;;=3^Mesna Inj 200mg
 ;;^UTILITY(U,$J,358.3,29775,0)
 ;;=J9213^^116^1483^51^^^^1
 ;;^UTILITY(U,$J,358.3,29775,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29775,1,1,0)
 ;;=1^J9213
 ;;^UTILITY(U,$J,358.3,29775,1,3,0)
 ;;=3^Interferon alfa-2a Inj 3 Mil U
 ;;^UTILITY(U,$J,358.3,29776,0)
 ;;=J9214^^116^1483^52^^^^1
 ;;^UTILITY(U,$J,358.3,29776,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29776,1,1,0)
 ;;=1^J9214
 ;;^UTILITY(U,$J,358.3,29776,1,3,0)
 ;;=3^Interferon alfa-2b Inj 1 Mil U
 ;;^UTILITY(U,$J,358.3,29777,0)
 ;;=J9217^^116^1483^56^^^^1
 ;;^UTILITY(U,$J,358.3,29777,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29777,1,1,0)
 ;;=1^J9217
 ;;^UTILITY(U,$J,358.3,29777,1,3,0)
 ;;=3^Lupron Depot Inj 7.5mg
 ;;^UTILITY(U,$J,358.3,29778,0)
 ;;=J9218^^116^1483^57^^^^1
 ;;^UTILITY(U,$J,358.3,29778,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29778,1,1,0)
 ;;=1^J9218
 ;;^UTILITY(U,$J,358.3,29778,1,3,0)
 ;;=3^Lupron Inj 1mg
 ;;^UTILITY(U,$J,358.3,29779,0)
 ;;=J9250^^116^1483^63^^^^1
 ;;^UTILITY(U,$J,358.3,29779,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29779,1,1,0)
 ;;=1^J9250
 ;;^UTILITY(U,$J,358.3,29779,1,3,0)
 ;;=3^Methotrexate Sodium Inj 5mg
 ;;^UTILITY(U,$J,358.3,29780,0)
 ;;=J9260^^116^1483^62^^^^1
 ;;^UTILITY(U,$J,358.3,29780,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29780,1,1,0)
 ;;=1^J9260
 ;;^UTILITY(U,$J,358.3,29780,1,3,0)
 ;;=3^Methotrexate Sodium Inj 50mg
 ;;^UTILITY(U,$J,358.3,29781,0)
 ;;=J9293^^116^1483^65^^^^1
 ;;^UTILITY(U,$J,358.3,29781,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29781,1,1,0)
 ;;=1^J9293
 ;;^UTILITY(U,$J,358.3,29781,1,3,0)
 ;;=3^Mitoxantrone HCl(Novan) Inj 5mg
 ;;^UTILITY(U,$J,358.3,29782,0)
 ;;=J9310^^116^1483^83^^^^1
 ;;^UTILITY(U,$J,358.3,29782,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29782,1,1,0)
 ;;=1^J9310
 ;;^UTILITY(U,$J,358.3,29782,1,3,0)
 ;;=3^Rituxam Inj 100mg
 ;;^UTILITY(U,$J,358.3,29783,0)
 ;;=J9360^^116^1483^91^^^^1
 ;;^UTILITY(U,$J,358.3,29783,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29783,1,1,0)
 ;;=1^J9360
 ;;^UTILITY(U,$J,358.3,29783,1,3,0)
 ;;=3^Vinblastine Sulfate (Velban) Inj 1mg
 ;;^UTILITY(U,$J,358.3,29784,0)
 ;;=J9370^^116^1483^92^^^^1
 ;;^UTILITY(U,$J,358.3,29784,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29784,1,1,0)
 ;;=1^J9370
 ;;^UTILITY(U,$J,358.3,29784,1,3,0)
 ;;=3^Vincristine Sulfate (VCR) Inj 1mg
 ;;^UTILITY(U,$J,358.3,29785,0)
 ;;=J9390^^116^1483^68^^^^1
 ;;^UTILITY(U,$J,358.3,29785,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29785,1,1,0)
 ;;=1^J9390
 ;;^UTILITY(U,$J,358.3,29785,1,3,0)
 ;;=3^Navelbine Inj 10mg
 ;;^UTILITY(U,$J,358.3,29786,0)
 ;;=J9171^^116^1483^33^^^^1
 ;;^UTILITY(U,$J,358.3,29786,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29786,1,1,0)
 ;;=1^J9171
 ;;^UTILITY(U,$J,358.3,29786,1,3,0)
 ;;=3^Docetaxel Inj 1mg
 ;;^UTILITY(U,$J,358.3,29787,0)
 ;;=J9070^^116^1483^21^^^^1
 ;;^UTILITY(U,$J,358.3,29787,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29787,1,1,0)
 ;;=1^J9070
 ;;^UTILITY(U,$J,358.3,29787,1,3,0)
 ;;=3^Cyclophosphamide Inj 100mg
 ;;^UTILITY(U,$J,358.3,29788,0)
 ;;=J9351^^116^1483^88^^^^1
 ;;^UTILITY(U,$J,358.3,29788,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29788,1,1,0)
 ;;=1^J9351
 ;;^UTILITY(U,$J,358.3,29788,1,3,0)
 ;;=3^Topotecan Inj 0.1mg
 ;;^UTILITY(U,$J,358.3,29789,0)
 ;;=J9035^^116^1483^12^^^^1
 ;;^UTILITY(U,$J,358.3,29789,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29789,1,1,0)
 ;;=1^J9035
 ;;^UTILITY(U,$J,358.3,29789,1,3,0)
 ;;=3^Bevacizumab Inj 10mg
